Overview

Aclidinium/Formoterol Fixed Combination Dose Finding Study

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The study seeks to determine the optimal dose of the Aclidinium/Formoterol combination for investigation in Phase III clinical trials
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Bromides
Formoterol Fumarate